Brachytherapy: An overview for clinicians

C Chargari, E Deutsch, P Blanchard… - CA: a cancer journal …, 2019 - Wiley Online Library
Brachytherapy is a specific form of radiotherapy consisting of the precise placement of
radioactive sources directly into or next to the tumor. This technique is indicated for patients …

Radiation oncology in the era of precision medicine

M Baumann, M Krause, J Overgaard, J Debus… - Nature Reviews …, 2016 - nature.com
Technological advances and clinical research over the past few decades have given
radiation oncologists the capability to personalize treatments for accurate delivery of …

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

F Cardoso, S Kyriakides, S Ohno… - Annals of …, 2019 - annalsofoncology.org
In 2018, the predicted number of new breast cancers in 28 European Union (EU) countries
was 404 920, with estimated age-adjusted annual incidence of breast cancer of 144.9/100 …

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node …

TJ Whelan, JA Julian, TS Berrang, DH Kim, I Germain… - The Lancet, 2019 - thelancet.com
Background Whole breast irradiation delivered once per day over 3–5 weeks after breast
conserving surgery reduces local recurrence with good cosmetic results. Accelerated partial …

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre …

CE Coles, CL Griffin, AM Kirby, J Titley, RK Agrawal… - The Lancet, 2017 - thelancet.com
Background Local cancer relapse risk after breast conservation surgery followed by
radiotherapy has fallen sharply in many countries, and is influenced by patient age and …

Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial

R Orecchia, U Veronesi, P Maisonneuve… - The Lancet …, 2021 - thelancet.com
Background In the randomised, phase 3 equivalence trial on electron intraoperative
radiotherapy (ELIOT), accelerated partial breast irradiation (APBI) with the use of …

[HTML][HTML] COVID-19: Global radiation oncology's targeted response for pandemic preparedness

R Simcock, TV Thomas, C Estes, AR Filippi… - Clinical and translational …, 2020 - Elsevier
As the global COVID-19 pandemic escalates there is a need within radiation oncology to
work to support our patients in the best way possible. Measures are required to reduce …

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

E Senkus, S Kyriakides, S Ohno… - Annals of …, 2015 - annalsofoncology.org
In 2012, the estimated age-adjusted annual incidence of breast cancer in 40 European
countries was 94.2/100 000 and the mortality 23.1/100 000 [1]. The incidence increased …

Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer …

JS Vaidya, M Bulsara, M Baum, F Wenz, S Massarut… - bmj, 2020 - bmj.com
Objective To determine whether risk adapted intraoperative radiotherapy, delivered as a
single dose during lumpectomy, can effectively replace postoperative whole breast external …

5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast …

V Strnad, OJ Ott, G Hildebrandt, D Kauer-Dorner… - The Lancet, 2016 - thelancet.com
Background In a phase 3, randomised, non-inferiority trial, accelerated partial breast
irradiation (APBI) for patients with stage 0, I, and IIA breast cancer who underwent breast …